TABLE 1.
Association between atypical antipsychotics and the incidence of dyslipidemia in the FAERS data.
| Drug A | Dyslipidemia with drug A | Dyslipidemia without drug A | ROR | Z score |
|---|---|---|---|---|
| Olanzapine | 2,970/68,084 (4.36%) | 60,845/11,369,947 (0.54%) | 8.48 | 111.3 |
| Quetiapine | 3,309/123,599 (2.68%) | 60,506/11,314,432 (0.53%) | 5.12 | 90.3 |
| Ziprasidone | 770/18,224 (4.23%) | 63,045/11,419,807 (0.55%) | 7.95 | 56.0 |
| Risperidone | 1,804/98,718 (1.83%) | 62,011/11,339,313 (0.55%) | 3.39 | 50.6 |
| Aripiprazole | 1,509/80,484 (1.87%) | 62,306/11,357,547 (0.55%) | 3.46 | 47.2 |
| Clozapine | 933/67,960 (1.37%) | 62,882/11,370,071 (0.55%) | 2.50 | 27.6 |